April 8, 2025 - 03:57

Troy Goldie has been appointed as the inaugural Chief Technology Officer (CTO) at GCI, marking a significant milestone for the company. Goldie, who previously held an executive position at Lumen Technologies, brings a wealth of experience and expertise to this newly-created role.
In his new position, Goldie will be responsible for overseeing GCI's technology strategy and implementation, aiming to enhance the company's competitive edge in the telecommunications sector. His appointment reflects GCI's commitment to innovation and improving customer experiences through advanced technology solutions.
Goldie's extensive background in the industry positions him well to lead GCI into a new era of technological advancement. His leadership will be crucial as the company navigates the rapidly evolving landscape of telecommunications and seeks to leverage new technologies to better serve its customers. The addition of a CTO underscores GCI's dedication to staying at the forefront of technology in a highly competitive market.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...